Virica Biotech and Ginkgo Bioworks Partner to Boost AAV Gene Therapy Production
Ginkgo Bioworks, Inc. is establishing a premier platform for cell programming and biosecurity, while Virica Biotech Inc. specializes in enhancers for scaling viral vectors and cell and gene therapies. The two companies have announced a strategic partnership to improve their…
Waud Capital Partners Acquires Science Exchange to Enhance Life Sciences Innovation
Science Exchange, a top provider of SaaS solutions for life sciences procurement and supplier management, has announced its acquisition by Waud Capital Partners, a private equity firm focused on growth in the software and healthcare sectors. This acquisition represents a…
PHC Showcases LiCellGrow Automated Cell Culture Prototype with In-Line Monitoring at Regenerative Medicine JAPAN 2024
PHC to Showcase LiCellGrow Prototype for Automated Cell Culture at Regenerative Medicine JAPAN 2024 PHC Corporation’s Biomedical Division will present the prototype of “LiCellGrow,” an automated cell culture device designed for developing cell medicine manufacturing processes, at the Regenerative Medicine…
Fresenius Kabi and Formycon Gain FDA Approval for Biosimilar Otulfi™ (ustekinumab-aauz)
Fresenius Kabi, part of Fresenius and specializing in biopharmaceuticals, clinical nutrition, and medical technologies, along with Formycon AG, an independent developer of biosimilars, has announced FDA approval for Otulfi™ (ustekinumab-aauz), a biosimilar referencing Stelara® (ustekinumab). Otulfi™ is approved for treating…
StemCardia Licenses Heart Regeneration Technologies from UW School of Medicine
StemCardia Inc. has secured a license for a range of intellectual property from CoMotion at the University of Washington (UW) and the UW School of Medicine, focusing on next-generation treatments for heart failure, the leading cause of death globally. The…
Repare Therapeutics Presents Phase 1 Data on Camonsertib and Radiotherapy at ASTRO Annual Meeting
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, today shared data showcasing the clinical benefits of camonsertib, a promising oral small molecule ATR inhibitor, used in combination with palliative radiation for treating metastatic tumors with an ataxia-telangiectasia-mutated (ATM)…
Synchron Reports Positive U.S. COMMAND Study Results for Brain-Computer Interface
Synchron, a brain-computer interface company, has announced positive results from the COMMAND study, which assessed the safety and efficacy of its BCI device in six participants over a 12-month period. The results of the COMMAND study were presented today at…
HealthStream Unveils Innovations for Privileging, Credentialing, and Data Management
HealthStream (Nasdaq: HSTM), a top healthcare technology platform for workforce solutions, showcased several innovations for CredentialStream® at the NAMSS 2024 Conference. CredentialStream is an industry-leading credentialing solution for healthcare organizations and is continually enhancing its capabilities to maintain its market…
MATTER Unveils First Paratus Digital Health Hub Accelerator in BARDA Network
MATTER, a leading healthcare incubator and innovation hub, has launched the inaugural accelerator program for the Paratus Digital Health Hub. Paratus is part of the Biomedical Advanced Research and Development Authority (BARDA), which operates under the U.S. Department of Health…
Henry Schein Launches Customer Assistance Hotline for Hurricane Helene
Henry Schein, Inc. (Nasdaq: HSIC) is reminding customers in Florida and areas expected to be impacted by Hurricane Helene that its Customer Assistance Hotline is available for dentists and physicians facing operational, logistical, or financial challenges due to the storm.…
Henry Schein Launches ‘Prepare to Care’ Program to Enhance Emergency Preparedness
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of health care solutions for dental and medical practitioners, has unveiled the “Prepare to Care” initiative through the Henry Schein Cares Foundation, Inc. (HSCF). This program aims to enhance emergency preparedness and…
Explore Henry Schein’s Digital Solutions and Financing Options at DS World
Henry Schein, Inc. (Nasdaq: HSIC) is set to make a splash at DS World with its educational FastPass session titled “Thrive at DS World with Henry Schein.” This session, designed for dental professionals, will take place at Caesars Forum in…